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Abstract
Background: Some data indicate that the dopaminergic and GABAergic systems interact in the vertebrate retina,
but the type of interactions is not well understood.
Methods: In this study we investigated the effect of dopamine D1 receptor blockade by 75 μM SCH 23390 on the
electroretinographic ON (b-wave) and OFF (d-wave) responses in intact frog eyecup preparations and in eyecups
where the ionotropic GABA receptors were blocked by 50 μM picrotoxin. Student’s t-test, One-way repeated
measures ANOVA with Bonferroni post-hoc test and Two-way ANOVA were used for statistical evaluation of the data.
Results: We found that SCH 23390 alone significantly enhanced the amplitude of the b- and d-waves without altering
their latency. The effect developed rapidly and was fully expressed within 8-11 min after the blocker application.
Picrotoxin alone also markedly enhanced the amplitude of the ERG ON and OFF responses and increased their latency
significantly. The effect was fully expressed within 25-27 min after picrotoxin application and remained very stable in
the next 20 min. The effects of SCH 23390 and picrotoxin are similar to that reported in our previous studies. When
SCH 23390 was applied on the background of the fully developed picrotoxin effect, it diminished the amplitude of the
b- and d-waves in comparison to the corresponding values obtained during application of picrotoxin alone.
Conclusion: Our results demonstrate that the enhancing effect of D1 receptor blockade on the amplitude of the ERG
b- and d-waves is not evident during the ionotropic GABA receptor blockade, indicating an interaction between these
neurotransmitter systems in the frog retina. We propose that the inhibitory effect of endogenous dopamine mediated
by D1 receptors on the ERG ON and OFF responses in the frog retina may be due to the dopamine-evoked GABA
release.
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Background
Dopamine is the most abundant catecholamine in the
vertebrate retina, while gamma-aminobutyric acid
GABA is the major retinal inhibitory neurotransmitter.
Dopamine is released by a specific set of dopaminergic
amacrine and/or interplexiform cells (reviews: [1, 2]). Its
actions are mediated by two classes of metabotropic
G protein-coupled receptors: 1) D1-class receptors
(including D1 and D5), which generally stimulate the
production of cAMP and protein kinase A (PKA) activity
and 2) D2-class receptors (including D2, D3 and D4), which
generally decrease the production of cAMP and PKA
activity. GABA is released by a large population of
GABAergic neurons identified as amacrine, interplexi-
form and horizontal cells (review: [3]). The actions of
GABA are mediated by 2 types of receptors: 1) iono-
tropic GABAA and GABAρ (GABAC) receptors, which
are ligand gated chloride channels and 2) metabotro-
pic G protein-coupled GABAB receptors that regulate
adenylyl cyclase, voltage-gated Ca2+ channels or in-
wardly rectifying K+ channels. One of the most intri-
guing questions in retinal physiology is how these
two important neurotransmitter systems interact and
what are the consequences of these interactions for
visual information processing?* Correspondence: epopova@abv.bg
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A few studies were undertaken in order to investigate
the functional effects of dopamine on the retinal
GABAergic system. Some authors reported that dopa-
mine and D1 receptor agonist SKF 38393 increased the
GABA-induced currents in rat retinal amacrine cells
through phosphorylation of GABAA receptors by PKA
[4]. Others demonstrated that dopamine and D1 recep-
tor agonist SKF 38393 selectively reduced the GABAC
receptor current in catfish cone horizontal cells. The
effect was mimicked by an adenylyl cyclase activator for-
skolin and blocked by the dopamine antagonist haloperi-
dol [5]. Dopamine and D1 receptor agonist SKF 38393
relieved the GABAergic inhibition, mediated mainly (but
not entirely) by GABAC receptors, of calcium entry in
most bipolar cell terminals in the tiger salamander retina
[6]. As a consequence of this effect, dopamine relieved
the GABAergic inhibition on the activity of third order
retinal neurons. Consistent with these results is a recent
finding that dopamine exerts a direct noncompetitive in-
hibition of human GABAρ, but not GABAA receptors,
expressed in Xenopus laevis oocytes [7]. The authors
proposed that “the binding site for dopamine in GABAρ1
receptor is different from the GABA binding site, and is
probably not located inside the channel pore”. Thus, it
appears that dopamine may have opposite effects on the
currents mediated by GABAA and GABAρ receptors in
single retinal neurons.
One of the easiest ways to investigate the global retinal
function in vivo without perturbing any neuronal con-
nections is through the use of an electroretinogram
(ERG). The ERG consists of many components, but two
components are most prominent in response to long
lasting stimuli: b-wave (in response to stimulus onset)
and d-wave (in response to stimulus offset). The b- and
d-waves are usually used for assessment of the retinal
ON and OFF channel activity. There is general consen-
sus that the neuronal generator of the b-wave is primar-
ily the depolarizing (ON) bipolar cells, while the d-wave
generation depends mainly on the activity of hyperpolar-
izing (OFF) bipolar cells with minor contribution of the
photoreceptor response at stimulus offset and activity of
proximal retinal neurons (reviews: [8, 9]). Therefore, the
significance of the dopamine-GABA system interactions
for the global retinal function could be revealed by
investigating the ERG changes during manipulation
(pharmacological or genetic) of the two systems. It has
been shown that both GABACR
-/- and D1R
-/- knockout
mice have smaller b-wave amplitude, reduced dark sensi-
tivity and compressed operational range of the rod-
driven b-wave, while the blockade of GABAA receptors
did not change these parameters of the response [10].
The GABA injections into D1R
−/− mice restored the light
sensitivity and operational range of b-waves, showing
that the lack of D1R-mediated signaling can be completely
masked by exogenous GABA. On the other hand, block-
ade of GABAC receptors had little additive effect on the b-
wave phenotype in D1R
−/− mice. Hence, the authors pro-
posed that dopamine acting on D1-class receptors induces
GABA release from horizontal cells and/or amacrine cells
and that GABA is responsible for dopamine effects on the
ERG b-wave. Smith et al. [11] argued, however, that the
activation of dopamine D1-class receptors suppressed ra-
ther than facilitated GABAergic modulation of mice rod
b-wave. They demonstrated that D1 receptor antagonist
SKF 83566 and GABAC receptor antagonist TPMPA as
well as D1 receptor agonist SKF 38303 had similar sup-
pressive effects on the rod-mediated b-wave amplitude
and sensitivity. Isolating GABAC receptor input to ON-
bipolar cells (with gabazine and strychnine) reversed the
effect of D1 receptor blockade on the amplitude and sensi-
tivity of the b-wave indicating that D1 receptors can sup-
press GABAC input to ON-BCs. The authors suggested
that the D1 receptor block disinhibited GABAA input to
GABAergic inhibitory cells that synapse onto ON BCs
GABAC receptors. The above cited studies provide no in-
formation concerning the effects of dopamine on the
GABAergic input to OFF bipolar cells because they used
brief light flashes, which did not allow separation of ERG
ON and OFF responses.
There are no ERG data with respect to dopamine-
GABA interactions in the non-mammalian retina. In this
study we investigated the effect of dopamine D1 receptor
blockade with SCH 23390 on the ERG b- and d-waves in
intact frog eyecup preparations and in eyecups where
the ionotropic GABA receptors were blocked by picro-
toxin. We found that the enhancing effect of SCH 23390
on the amplitude of the both ERG waves is not evident
during the GABAergic blockade.
Methods
The experiments were carried out on dark adapted eye-
cup preparations of the frog (Rana ridibunda), continu-
ously superfused with Ringer solution (NaCl 110 mM,
KCl 2.6 mM, NaHCO3 10 mM, CaCl2 1.6 mM, MgCl2
0.8 mM, Glucose 2 mM; HCl 0.5 mM to adjust pH to
7.8) at a rate of 1.8 – 1.9 ml/min, at 16-18 °C and
supplied with moistened O2. The frogs were first anes-
thetized in water containing 500 mg/l Tricaine methane-
sulfonate (Sigma-Aldrich Chemie GmbH). They were
then decapitated and pithed. The experimental proced-
ure has been approved by protocol № 8/15.04.2015 from
the Committee for ethics in scientific research of
Medical University of Sofia, Bulgaria. The D1-class dopa-
mine receptors were blocked by using SCH 23390
(Sigma-Aldrich Chemie GmbH) dissolved in Ringer so-
lution to a concentration of 75 μM. This concentration
was chosen among other concentrations tested (25 μM
and 50 μM) because it had maximal effect on the
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amplitude of both ERG waves (see Additional file 1).
The ionotropic GABAA and GABAρ receptors were
blocked by using 50 μM picrotoxin (Flika, Buchs,
Switzerland) dissolved in the perfusion solution. The
same concentration of picrotoxin has been used in many
of our previous studies [12–14]
Experimental procedure
The frogs were dark adapted for 24 h and then the eye-
cups were prepared under dim red light. The rhythmic
light stimulation began after additional period of dark
adaptation for 10 min. Diffuse white light stimuli
(150 W tungsten halogen lamp) with 5 s duration were
presented repeatedly at interstimulus interval of 25 s.
The light intensity was 6 × 102 quanta s-1 μm-2 falling at
the plane of the retina. The stimulus intensity was
chosen on the basis of our previous experiments
showing that it generates responses in the steepest part
of the V – log I function for both the b- and d-waves in
dark adapted frog eyecups [12, 15, 16]. Using of long
stimuli may light adapt the retina, but it is not expected
to change the drug effects because it has been shown in
many of our previous works that the effects of SCH
23390 and PT did not depend critically on the state of
light adaptation [12, 14, 15].
The results are based on 33 experiments, divided into
4 experimental groups according to the substances ap-
plied: 1) Control group (n = 8). The eyecups were per-
fused with Ringer solution throughout the whole 55 min
period. 2) SCH 23390 group (n = 8). The eyecups were
perfused with Ringer solution for 10 min first and then
with 75 μM SCH 23390 for 25 min. In one of the experi-
ments the perfusion was switched again to Ringer solu-
tion for 15 min in order to follow the recovery from the
SCH 23390 effects. 3) Picrotoxin group (n = 9). The eye-
cups were perfused with Ringer solution for 10 min first
and then with 50 μM picrotoxin for 45 min. The recov-
ery from picrotoxin effects was not investigated in the
present study because it has been demonstrated in our
previous work [13]. 4) Picrotoxin + SCH 23390 group
(n = 8). The eyecups were consequently perfused with
Ringer solution (for 10 min), 50 μM picrotoxin (for
27 min) and 50 μM picrotoxin + 75 μM SCH 23390
(for 18 min).
ERG recording and data analysis
The electroretinograms were recorded by means of non-
polarized Ag/AgCl electrodes at bandpass of 0.1 -
1000 Hz (DC/AC differential amplifier model 3000; A-M
Systems) and digitized at 2000 Hz, 16 bit resolution
(Data acquisition system Biopac MP 150). The amplitude
of the b-wave was measured from the peak of the a-
wave to the peak of the b-wave, while that of the d-wave
was measured from the baseline to the peak of the wave.
Then the amplitudes were normalized to the values ob-
tained in the 10th minute from the beginning of the ex-
periments because it was the last minute of the control
period. The latency of the ERG waves was measured
from the stimulus onset (for b-wave) or offset (for d-
wave) to the beginning of the wave. The latency was
measured in the following time points from the begin-
ning of the experiment: 10th minute - last minute of the
control period; 21st minute – time when the SCH 23390
effects reached their maximum; 37th minute – time
when the picrotoxin effects reached their maximum and
it was the last minute prior to switching the perfusion to
picrotoxin + SCH 23390; 48th minute – time when the
SCH 23390 effects were expected to reach their maximum
during combined picrotoxin + SCH 23390 application.
Two-way ANOVA (OriginPro 8 software, OriginLab
Corporation, Northhampton, MA) was used for statis-
tical evaluation of the differences in the normalized
amplitude values between different groups. One-way re-
peated measures ANOVA with Bonferroni post-hoc test
was used to evaluate the period where the blocker effect
on the ERG wave amplitude was stable in time (plateau
period). Paired t-test was used for statistical evaluation
of the latency changes in each group at the above
mentioned time points (compared to the 10th minute).
A p value of <0.05 was considered significant.
Results
Control group
The amplitude of the b-wave remained unchanged dur-
ing the entire course of the control experiments. This is
demonstrated in Figs. 1a and 2a, where the b-wave amp-
litude was normalized to the value (266 ± 56.12 μV)
obtained in the 10th minute from the beginning of
the experiments. The normalized d-wave amplitude
(100% = 91 ± 27.7 μV) showed a tendency for small
diminution, which is typical for the OFF responses in
these stimulation conditions (Fig. 1b; Fig. 2b). The la-
tency of the ERG waves was not significantly altered
during the perfusion with Ringer solution (Table 1).
SCH 23390 group
The amplitude of the ERG waves was relatively stable in
the initial control period when the eyecups were per-
fused with Ringer solution only. Switching the perfusion
to 75 μM SCH 23390 caused an increase of the ampli-
tude of the b-wave (to ~ 127%) and d-wave (to ~ 137%)
with respect to their initial values (100% = 195 ± 36.74 μV
for the b-wave; 100% = 61 ± 13.18 μV for the d-wave)
(Figs. 1 a, b). The effect developed rapidly and reached a
plateau sooner for the b-wave (7th min from the be-
ginning of SCH 23390 perfusion) than for the d-wave
(11th min) (Figs. 1a, b). The effect of the blocker dur-
ing the plateau period was very stable in time. There
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were no significant differences between the mean values
of the normalized ERG wave amplitude at different time
points during that period as revealed by Bonferroni
post-hoc test and One-way repeated measures ANOVA
with Greenhouse-Geisser correction (F (1.65, 11.58) = 0.82,
p > 0.05 for the b-wave; F(2.1, 14.73) = 1.20, p > 0.05 for the
d-wave). During the plateau period, the amplitudes of the
b- and d-waves were significantly higher than the cor-
responding values obtained in the control group
(Two-way ANOVA, F (1,159) = 385.1, p < 0.001 for the
b-wave; F (1,159) = 433.4, p < 0.001 for the d-wave). Perfu-
sion with SCH 23390 did not significantly alter the latency
of the ERG waves (Table 1). These results are consistent
with our previous findings in the dark adapted frog retina
[15, 16] and indicate that endogenous dopamine acting
through D1 receptors has a suppressive action on the
amplitude of the ERG ON and OFF responses. The ampli-
tude of the ERG waves recovered considerably when the
perfusion was switched again to Ringer solution (Fig. 1 c).
Picrotoxin group
Perfusion with 50 μM picrotoxin caused a consider-
able increase of the amplitude of the b-wave (~300%)
and d-wave (~530%) in comparison to their initial
values (b-wave: 100% = 263 ± 38.25 μV; d-wave: 100% =
108 ± 18.40 μV) (Figs. 2 a, b). The effect developed much
slower than that of SCH 23390 and reached a plateau after
25 min from the beginning of picrotoxin perfusion. After
that time, the effect was very stable till the end of the ex-
periment (Figs. 2 a, b, c). No significant difference between
the mean values of normalized ERG wave amplitude at
different time points during the plateau period was ob-
served as revealed by Bonferroni post-hoc test and One-
way repeated measures ANOVA with Greenhouse-Geisser
correction (F(2.78, 22.28) = 2.63, p > 0.05 for the b-wave;
F(1.82, 14.58) = 1.02, p > 0.05 for the d-wave). During the
plateau period, the amplitudes of both ERG waves
were significantly greater compared to the corre-
sponding values obtained in the control experiments
(Two-way ANOVA, F (1,157) = 1011.6, p < 0.0001 for the b-
wave; F (1,157) = 630.1, p < 0.001 for the d-wave). Picrotoxin
not only altered the amplitude of the ERG responses, but
also significantly delayed their latencies (Table 1). These
results are in line with our previous data showing that the
blockade of ionotropic GABA receptors in the frog retina
always has an enhancing effect on the amplitude of the b-
and d-waves combined with lengthening of their latencies
irrespective of adaptation state and stimulus intensity used
[13; for review: 3]. This means that activation of ionotro-
pic GABA receptors by endogenous GABA leads to dim-
inution of the amplitude, but speeds up the time courses
of the ERG ON and OFF responses.
Fig. 1 Effects of SCH 23390 on the ERG waves a, b Time course of the effects of SCH 23390 on the amplitudes of the ERG b- and d-waves. Results
of both control experiments (R, open symbols) and test experiments (SCH, filled symbols) are represented. The amplitudes of the ERG waves were
normalized to the values obtained in the 10th minute from the beginning of the experiments. The time when the perfusion was switched to
75 μM SCH 23390 (SCH) are indicated by arrows. Mean values ± SEM are shown. c Original ERG records (b- and d-wave) obtained during the
perfusion with Ringer solution (R) in the control period (10th minute from the beginning of the experiment - upper row), 75 μM SCH 23390
(21st minute from the beginning of the experiment - middle row) and Ringer solution (R) in the recovery period (50th minute from the beginning
of the experiment - bottom row). The stimulus onset and offset are indicated below the traces. Calibration: time – 0.2 s; amplitude – 50 μV
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Picrotoxin + SCH 23390 group
After the initial control period, the eyecups in this
group were treated with picrotoxin alone for 27 min
and with a combination of picrotoxin and SCH 23390
afterwards. As it could be expected from the results
of the previous group, perfusion with picrotoxin alone
caused a great enhancement to the amplitude of the
b- wave (to ~ 300%; 100% = 194 ± 27.77 μV) and d-wave
(to ~ 457%; 100% = 62 ± 9.2 μV) and lengthening of its re-
sponse latency (Figs. 2 a, b, c) (Table 1). We compared the
increase of the amplitude of the ERG waves in this group
with that obtained in the picrotoxin group. No significant
differences were obtained between the two groups
(Two-way ANOVA, F (1,130) = 0.66.6, p > 0.05 for the
b-wave; F (1,131) = 2.13, p >0.05 for the d-wave for the
time between 30th and 37th minute from the begin-
ning of the experiment). This indicates that the picro-
toxin effect was expressed to a similar degree in both
groups and thus, we could expect that it would have
a similar time course. When the perfusion was switched
to the solution containing picrotoxin and SCH 23390
(37th minute from the beginning of the experiment), a
diminution of the amplitudes of the b- and d-waves was
evident (Figs. 2 a, b). The effect developed rapidly and
reached a plateau 8-10 min after the beginning of the
picrotoxin + SCH 23390 perfusion. The plateau period
was confirmed by Bonferroni post-hoc test and One-
way repeated measures ANOVA with Greenhouse-
Geisser correction (F(2.76, 19.31) = 0.89, p > 0.05 for the
b-wave; F(2.30, 16.13) = 0.67, p > 0.05 for the d-wave),
which revealed no significant differences between the
mean values of normalized ERG wave amplitude at
different time points during that period. The time
course of the described effect resembled the time
course of the effect of SCH 23390 alone, but was in
the opposite direction. We compared the normalized
amplitude values of the ERG waves during combined
picrotoxin plus SCH 23390 treatment to its value ob-
tained in picrotoxin group during the same time
period (43 – 52 min). Two-way ANOVA revealed a
significant difference between the two groups (F (1,169)
= 30.96, p < 0.0001 for the b-wave; F (1,169) = 35.21, p <
0.0001 for the d-wave). This means that SCH 23390
applied on the background of the GABAergic blockade,
significantly decreased the b- and d-wave amplitudes. The
perfusion with picrotoxin + SCH 23390 did not signifi-
cantly alter the latencies of the ERG responses as com-
pared to that obtained during the preceding perfusion
with picrotoxin alone (Table 1). This result could be ex-
pected because SCH 23390 alone also had no significant
effect on this response parameter.
It was very interesting to investigate the interactions
between the GABAergic system mediated by ionotro-
pic GABA receptors and the dopaminergic system
mediated by D1 receptors when their respective
blockers were applied in the reverse order. However,
the results from such experiments where SCH 23390
was applied first and then picrotoxin was co-applied
could not be informative because the effects of SCH
23390 were not very stable at that time. The effects
of SCH 23390 upon the d-wave amplitude declined
after ~ 25 min from the beginning of the blocker per-
fusion (Fig. 3). If we switch the perfusion from SCH
23390 to SCH 23390 + picrotoxin after 11-12 min
from the beginning of SCH 23390 perfusion (when
the maximum of SCH effect is reached), we will only
have 13-14 min with stable SCH 23390 effect upon
the d-wave amplitude. During this short time period,
Table 1 Effects of SCH 23390, picrotoxin and combined picrotoxin + SCH 23390 application on the latency of the ERG b- and d-waves,
obtained at different time periods (minutes from the beginning of the experiment)
Group Latency (ms) 10 min 21 min 37 min 48 min
R b-wave 115 ± 4.92 112 ± 6.58 111 ± 3.09 110 ± 5.20
d-wave 104 ± 5.05 100 ± 7.14 105 ± 8.54 97 ± 8.45
SCH b-wave 113 ± 3.47 117 ± 5.28
d-wave 95 ± 6.66 106 ± 8.77
PT b-wave 124 ± 7.36 135 ± 6.74 133 ± 7.21
p < 0.008
d-wave 104 ± 6.91 127 ± 7.60 127 ± 7.29
p < 0.00002
PT+SCH b-wave 127 ± 5.21 133 ± 5.98 133 ± 7.05
p < 0.042
d-wave 112 ± 6.81 131 ± 7.60 127 ± 9.5
p < 0.018
The statistical significance of the differences between the values obtained before (10 min) and after drug application (37 min) is evaluated using paired t-test.
Means ± SEM are shown
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picrotoxin effects could not reach their maximal ex-
pression. Thus, the effect of the GABAergic blockade
could not be investigated on the background of stable
D1 receptor blockade. As a consequence, no conclu-
sion could be drawn for the interaction between the
two systems (especially for the OFF response).
Discussion
Our results clearly show that the isolated blockade of
dopamine D1 receptors and ionotropic GABA receptors
have enhancing effects on the amplitudes of both the
ON and OFF responses in a frog ERG. This means that
endogenous dopamine acting through D1-class receptors
as well as endogenous GABA acting through ionotropic
GABA receptors decreases the amplitudes of the ERG b-
and d-waves. Our results are in odds with the results
showing that the b-wave amplitude is suppressed in ret-
inas with compromised D1 receptor function (fish: [17];
rabbit: [18, 19]; mouse: [10, 20–22]). The cited results
indicate that the activation of D1 receptors by endogen-
ous dopamine in fish, mouse and rabbit retinas enhances
the b-wave amplitude. As the activities of ON bipolar
cells are the main neuronal generators of the b-wave, it
means that the light responses of ON bipolar cells are
probably enhanced under the influence of dopamine D1
receptor activation. Unfortunately, the effects of selective
D1 receptor agonists and antagonists on the light re-
sponses of single ON and OFF bipolar cells were not
thoroughly investigated in different species. It has been
shown, however, that dopamine, acting through D1-class
dopamine receptors, enhances the response to glutamate
in amphibian OFF bipolar cells [23]. As glutamate is the
neurotransmitter of photoreceptors, it is reasonable to
expect that the enhanced glutamate-gated current in
OFF bipolar cells would enhance their light responses. A
similar suggestion could be made from the results
reported in the zebrafish retina, where dopamine de-
creases the voltage-activated potassium currents via D1
receptor-coupled G-protein pathways in ON bipolar
cells [24]. All these indirect data led to the suggestion
that activation of D1 receptors would enhance the light
responses of both the ON and OFF bipolar cells.
If activation of D1 receptors has a similar action in the
frog retina why then does SCH 23390 enhance rather than
Fig. 2 Effects of picrotoxin and picrotoxin plus SCH 23390 on the ERG waves a, b Time course of the effects of picrotoxin (PT) and picrotoxin
plus SCH 23390 (PT + SCH) on the amplitudes of the ERG b- and d-waves. The results of different groups are indicated with open symbols in
control experiments; hemi filled symbols in PT experiments and filled symbols in PT + SCH experiments. The amplitudes of the ERG waves were
normalized to the values obtained just prior to picrotoxin application (10th minute from the beginning of the experiment). The times when the
perfusion was switched to PT and PT + SCH are indicated by arrows. Mean values ± SEM are shown. c Original ERG records (b- and d-waves)
obtained in the PT group during the perfusion with Ringer solution in the control period (10th minute from the beginning of the experiment -
upper row) and during the perfusion with 50 μM picrotoxin: 37th minute (middle row) and 48th minute (bottom row) from the beginning of the
experiment. The stimulus onset and offset are indicated below the traces. Calibration: time – 0.2 s; amplitude – 50 μV. d Original ERG records
(b- and d-wave), obtained in the PT + SCH group during the perfusion with Ringer solution in the control period (10th minute from the beginning
of the experiment - upper row), 50 μM picrotoxin (37th minute from the beginning of the experiment - middle row) and 50 μM picrotoxin +
75 μM SCH 23390 (48th minute from the beginning of the experiment - bottom row). The stimulus onset and offset are indicated below the
traces. Calibration: time – 0.2 s; amplitude – 50 μV
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diminish the b- and d-wave amplitudes? One possible ex-
planation is that dopamine, acting on D1 receptors, re-
leases GABA from the GABAergic neurons. GABA would
decrease the b- and d-wave amplitudes through its action
on ionotropic GABA receptors. If ionotropic GABA re-
ceptors are blocked, however, this action of GABA would
be prevented and dopamine D1 receptor activation would
have an enhancing action on the ERG ON and OFF re-
sponses. We indeed demonstrated that the application of
SCH 23390 during the ionotropic GABA receptor block-
ade caused a diminution instead of enhancement of the
amplitude of both the b- and d-waves. Thus, it seems pos-
sible that the enhancing effect of D1 receptor activation
on the ERG waves in the frog retina is obscured by the
suppressive action of GABA released under the influence
of dopamine. Dopamine D1 receptor inducing GABA re-
lease has been proposed to exist in the mouse retina [10]
and is documented in the presence of free Ca2+ in the fish
retina [25]. Because an opposite effect of dopamine on the
GABA release was seen in Ca2+-free medium, it has been
proposed that dopamine stimulates Ca2+-dependent
GABA release and inhibits Ca2+-independent GABA re-
lease [25]. The latter suggestion is supported by other
authors who have shown that dopamine acting through
D1-class receptors fully inhibits the Ca
2+-independent re-
lease of GABA in the fish retina [26–28]. Other authors
insist, however, that dopamine only partly inhibits the
Ca2+-independent release of GABA (rat:[29]) or that
dopamine and D1 receptor agonist SKF 38393 inhibit
the Ca2+-independent release of GABA only when NMDA
receptors are activated (in Mg2+-free medium) (chick:
[30]). An intriguing fact is that the latter effect of dopa-
mine is not prevented by the antagonists of both dopa-
mine receptor classes [30]. It was demonstrated [31] that
dopamine and SKF 38393 bind to the NMDA channel and
block it by a voltage-dependent mechanism in embryonic
chick neurons. Similar effect has been seen in neonatal
striatal neurons, but not in adult animals, where dopamine
D1 receptor activation produces a potentiation of the
NMDA response [32]. It remains to be determined if simi-
lar developmental switch in D1 modulation of NMDA re-
ceptors occurs in the retina. More studies are needed to
understand the effect of dopamine D1 receptor activation
on GABA release and GABAergic neurotransmission in
vertebrate retina.
Conclusion
Our results clearly show that an isolated D1 dopamine
receptor blockade by SCH 23390 as well as an isolated
ionotropic GABA receptor blockade by picrotoxin has
an enhancing effect on the b- and d-wave amplitudes in
a frog ERG. The enhancing effect of D1 receptor block-
ade is not seen during simultaneous application of picro-
toxin, indicating that there is a significant interaction
between dopaminergic and GABAergic systems in the
frog retina.
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